TMO Stock
Thermo Fisher Scientific, Inc.
—
Price
Daily closes via Alpaca (IEX); today's point is the latest trade.
Key stats
Valuation
P/E (trailing)35.7
Forward P/E25.5
Price / sales5.3
Price / book4.6
EPS (12 mo)$18.94
Dividend yield0.29%
Beta0.83
Financial health last 12 months
Revenue growth+8.3%
Earnings growth+9.4%
Gross margin41.2%
Net margin+14.9%
Return on equity13.3%
Debt / equity0.76
Hover a figure for what it means.
Analyst ratings Nov 2026 · 34 analysts
Consensus: Buy
Strong buy 11Buy 16
Hold 7Sell 0
Strong sell 0
| Month | Buy | Hold | Sell | Consensus |
|---|---|---|---|---|
| Nov 2026 | 27 | 7 | 0 | Buy |
| Oct 2026 | 30 | 5 | 0 | Buy |
| Sep 2026 | 29 | 7 | 0 | Buy |
| Aug 2026 | 29 | 7 | 0 | Buy |
Latest news
A $12 Billion Fund Just Bought These 3 Stocks
Yahoo · 16h ago
Thermo Fisher Scientific (TMO): A Sharp Valuation Shift Prompted the Strategy to Exit the Position
Yahoo · 1d ago
Stanley Druckenmiller, Dan Loeb and 12 Other Big Funds Sold Danaher Last Quarter, While 26 Bought. Who’s Right?
Yahoo · 1d ago
Headlines from the last 10 days via Finnhub; links open the publisher's article.
Next earnings
No report scheduled in the next 4 months.
Past earnings moves
No tracked reports yet. TradeSphere saves the expected and actual move for every report from Nov 3, 2026 on, for stocks on the Earnings page.